glp 1 receptor brain GLP-1 agonists show promise in treating substance use disorders Nature: Dual-active molecules targeting GLP-1R

In addition, new drugs such as tirzepatide have come onto the market, expanding the therapeutic options for successful treatment of T2DM and obesity

Studies have shown that variations in the GIPR gene are linked to cardiovascular disease and metabolic syndrome characteristics, which supports this idea [110]

If your blood pressure consistently improves, your provider can decide whether your medication plan should stay the same or be adjusted

This segment aired on March 24, 2026.

Semaglutide GLP-1 is worth it, as you deserve to look and feel your best

Phase 3 focuses on 9 mg and 12 mg as the primary dose arms (with 4 mg included in some trials)